| __timestamp | Supernus Pharmaceuticals, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19586000 | 22223073 |
| Thursday, January 1, 2015 | 29135000 | 6966842 |
| Friday, January 1, 2016 | 42791000 | 9000499 |
| Sunday, January 1, 2017 | 49577000 | 13741186 |
| Monday, January 1, 2018 | 89209000 | 19040000 |
| Tuesday, January 1, 2019 | 69099000 | 23559000 |
| Wednesday, January 1, 2020 | 75961000 | 31931000 |
| Friday, January 1, 2021 | 90467000 | 44981000 |
| Saturday, January 1, 2022 | 74552000 | 54234000 |
| Sunday, January 1, 2023 | 91593000 | 63806000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Supernus Pharmaceuticals, Inc. and Viking Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Supernus Pharmaceuticals consistently increased its R&D budget, peaking in 2023 with a 367% rise from its 2014 levels. This strategic investment underscores their commitment to advancing neurological therapies. Meanwhile, Viking Therapeutics, though starting with a modest budget, exhibited a remarkable 187% growth in R&D spending over the same period, reflecting its aggressive push into metabolic and endocrine disorder treatments.
This comparative analysis highlights the diverse strategies within the biotech sector, where both companies leverage R&D to fuel innovation and maintain competitive edges in their respective fields.
Novartis AG or Viking Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Bristol-Myers Squibb Company and Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: GSK plc and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and Viking Therapeutics, Inc.
Comparing Innovation Spending: Pharming Group N.V. and Supernus Pharmaceuticals, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and Viking Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for MorphoSys AG and Supernus Pharmaceuticals, Inc.
HUTCHMED (China) Limited vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Supernus Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.: Strategic Focus on R&D Spending
R&D Spending Showdown: Supernus Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.